Astragaloside IV Alleviates Systemic Lupus Erythematosus by Modulating ITGB1/PTK2/p38 Pathway: Integrated Network Pharmacology and Experimental Validation

Zhongfu Tang, Lili Cheng, Ming Li, Chuanbing Huang Department of Rheumatology, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, People’s Republic of ChinaCorrespondence: Chuanbing Huang, Department of Rheumatology, The First Affiliated Hospital of Anhui Unive...

Cijeli opis

Bibliografski detalji

Glavni autori:	Tang Z, Cheng L, Li M, Huang C
Format:	Artigo
Jezik:	Inglês
Izdano:	Dove Medical Press 2025-10-01
Serija:	Drug Design, Development and Therapy
Teme:	Astragaloside IV systemic lupus erythematosus immune function inflammatory factors network pharmacology
Online pristup:	https://www.dovepress.com/astragaloside-iv-alleviates-systemic-lupus-erythematosus-by-modulating-peer-reviewed-fulltext-article-DDDT
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!